+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Automated & Closed Cell Therapy Processing Systems Market - Global Forecast to 2030- Product Image
Automated & Closed Cell Therapy Processing Systems Market - Global Forecast to 2030- Product Image
New

Automated & Closed Cell Therapy Processing Systems Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6081813
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Automated & Closed Cell Therapy Processing Systems Market grew from USD 1.08 billion in 2024 to USD 1.26 billion in 2025. It is expected to continue growing at a CAGR of 15.85%, reaching USD 2.63 billion by 2030.

Cell therapy has emerged as a cornerstone of modern medicine, offering unprecedented avenues for treating complex diseases and personalized therapies. As demand for consistent, high-quality cell products surges, automated and closed cell therapy processing systems have become critical to streamlining manufacturing workflows, reducing contamination risks, and ensuring regulatory compliance. This executive summary outlines the current landscape of automated and closed processing technologies, highlights transformative industry shifts, examines the 2025 United States tariffs and their cumulative effects, and delivers strategic insights across segmentation, regional developments, and leading companies. By synthesizing the latest advancements and market dynamics, this overview equips decision-makers and experts with a comprehensive understanding of the forces driving innovation and adoption in cell therapy manufacturing. Transitioning from manual, open-process environments to integrated, closed-loop systems not only accelerates production timelines but also enhances reproducibility and scalability-key imperatives for meeting the stringent demands of clinical operations, biopharmaceutical production, and cutting-edge research.

Transformative Shifts Shaping the Cell Therapy Processing Landscape

Over the past decade, the cell therapy processing arena has undergone a profound metamorphosis driven by technological breakthroughs, evolving regulatory frameworks, and shifting stakeholder priorities. First, the proliferation of single-use bioreactors and modular automation platforms has catalyzed a shift away from labor-intensive, open-processing workflows toward seamless, closed-loop systems that minimize contamination risk and human error. Simultaneously, artificial intelligence-powered process monitoring and predictive analytics are transforming Quality by Design (QbD) initiatives, enabling real-time adjustments to critical parameters such as cell density, viability, and phenotype.

Regulatory bodies worldwide are also enacting more flexible yet stringent guidelines to support accelerated approval pathways for cell-based therapies, prompting manufacturers to invest heavily in compliance assistance and validation services. In parallel, advances in cryopreservation techniques-particularly controlled-rate freezing and vitrification-are redefining supply chain resilience by safeguarding cell integrity during storage and transport. Moreover, integrated consumable and reagent innovations, including serum-free culture media and next-generation enzymes, are further optimizing yield and purity.

Together, these transformative shifts are reshaping the competitive landscape, compelling both established players and emerging innovators to adopt holistic, end-to-end solutions that address scalability, reproducibility, and cost-efficiency.

Assessing the 2025 United States Tariffs: Cumulative Impacts on the Market

The imposition of revised United States tariffs in 2025 has introduced a layer of complexity to global supply chains for cell therapy processing equipment, consumables, and reagents. Tariff increases on imported bioreactors, centrifuges, and single-use plastics have elevated production costs for both hardware manufacturers and end-users. In response, many suppliers are localizing key manufacturing operations to mitigate duty burdens while maintaining competitive pricing.

At the same time, customs delays and increased compliance scrutiny have underscored the importance of strategic sourcing and near-shoring initiatives. Organizations with diversified supplier networks have demonstrated greater resilience, offsetting tariff impacts through alternative regional partnerships. Additionally, the need for enhanced documentation and classification of therapeutic-grade consumables has driven demand for specialized regulatory compliance assistance and validation services, ensuring uninterrupted workflow continuity.

Although the cumulative tariff adjustments have exerted upward pressure on operating expenses, they have also accelerated investment in automation and closed-loop systems, which deliver long-term cost savings through reduced labor, minimized waste, and optimized resource utilization.

Key Segmentation Insights Across Products, Applications, and Workflow Processes

A nuanced understanding of market segmentation is fundamental to identifying growth opportunities and aligning product portfolios with end-user requirements. Based on product type, the landscape encompasses automated processing systems, closed cell processing systems, and open processing systems; within the closed cell category, post-cryopreservation, pre-cryopreservation, and scalable systems each address distinct stages of cell therapy manufacturing. Application-driven segmentation spans biopharmaceutical manufacturing, clinical operations, and research institutes, with biopharmaceutical manufacturing further divided into monoclonal antibodies, recombinant proteins, and vaccines-segmented again into prophylactic and therapeutic vaccines. Clinical operations include hematology, oncology, and patient-specific therapy, with oncology subdivided into hematologic malignancies and solid tumors, while research institutes focus on cell therapy research, gene editing, and stem cell research.

End users range from biotechnology companies, hospitals and clinics, pharmaceutical companies to research and academic institutes, with hospitals and clinics encompassing both oncology clinics and specialized treatment centers. Workflow processes cover cell cryopreservation-incorporating controlled-rate freezing and vitrification-cell expansion, cell harvesting, and cell separation. Consumables and reagents include enzymes (nucleases and proteases), mediums and supplements, and serum-free culture reagents. Technological component segmentation highlights hardware (bioreactors and centrifuges), services (regulatory compliance assistance and validation services), and software (data analysis and process monitoring). Type of cells spans NK cells, stem cells-differentiated into adult and embryonic stem cells-and T-cells, including CAR-T cells and engineered T-cells. Finally, manufacturing scale segmentation distinguishes clinical, industrial, and research scales, each demanding tailored solutions to meet throughput, regulatory, and budgetary constraints.

Key Regional Insights Driving Adoption in Major Global Markets

Regional dynamics play a pivotal role in shaping the adoption trajectories of automated and closed cell therapy processing systems. In the Americas, robust investment in biotechnology and biopharma manufacturing infrastructure, coupled with supportive regulatory frameworks, has fueled the uptake of integrated automation platforms and scalable closed-loop workflows. Europe, Middle East, and Africa benefit from a collaborative innovation ecosystem, particularly in Western Europe, where government grants and public-private partnerships have accelerated the deployment of AI-driven process monitoring and advanced cryopreservation solutions. Emerging markets in the Middle East and Africa are increasingly leveraging technology transfer agreements and localized production models to overcome infrastructure gaps.

In the Asia-Pacific region, rapid expansion of contract development and manufacturing organizations-supported by favorable reimbursement policies in key markets such as Japan, South Korea, and Australia-has driven demand for versatile hardware and turnkey services. Additionally, initiatives to standardize regulatory pathways across ASEAN nations are lowering barriers to entry, enabling multicenter clinical studies and advanced research collaborations. These regional insights highlight the importance of tailored market entry strategies and partnerships that align with local regulatory landscapes and infrastructure capabilities.

Key Companies Insights: Leaders Innovating Cell Therapy Processing

The competitive landscape spans a spectrum of established life-science giants and specialized innovators, each contributing unique value propositions. Bio-Techne Corporation and Thermo Fisher Scientific, Inc. lead with comprehensive portfolios of reagents, instruments, and software analytics. Lonza Group AG and Merck KGaA stand out for their cell expansion systems and serum-free media innovations, while Danaher Corporation and GE demonstrate strength in single-use bioreactors and downstream processing equipment. Sartorius AG and Cytiva excel in modular automation platforms and process monitoring tools, complemented by specialized service offerings from STEMCELL Technologies Canada Inc. and BioLife Solutions Inc.

Cellares Inc. and Miltenyi Biotec B.V. & Co. KG are at the forefront of closed-loop processing technology, integrating hardware, software, and regulatory validation. Corning Incorporated and Fresenius SE & Co. KGaA focus on consumable solutions, including advanced plastics and controlled-rate freezing systems. Novartis AG and Pluristem Therapeutics Inc. exemplify end-to-end clinical adoption, deploying proprietary cell therapy processing workflows in patient-specific applications. BioSpherix, Ltd. and Regeneus Ltd. pioneer niche cryopreservation and cell culture platforms, while Terumo Corporation, General Electric Company, and Thermogenesis Holdings, Inc. extend the market reach with complementary hardware, software, and services designed to enhance process scalability and quality assurance.

Actionable Recommendations for Industry Leaders in Cell Therapy Processing

To capitalize on the rapidly evolving cell therapy processing market, industry leaders should prioritize strategic initiatives that balance innovation with operational efficiency. First, integrating AI-driven process monitoring solutions into existing automation platforms will enable proactive quality control and reduce batch failures. Second, establishing regional manufacturing hubs in tariff-sensitive markets will mitigate duty exposure while accelerating supply chain responsiveness. Third, forging collaborative partnerships with contract development and manufacturing organizations can expand service offerings and unlock new revenue streams.

Additionally, diversifying consumables portfolios to include next-generation enzymes and serum-free reagents will address stringent regulatory requirements and support a broader range of applications. Investing in workforce development-through specialized training programs in closed-loop operation and regulatory compliance-will ensure seamless adoption of advanced technologies. Finally, adopting a modular, scalable architecture for both hardware and software components will future-proof manufacturing lines, enabling rapid adaptation to emerging cell types and therapeutic modalities.

Conclusion: Embracing Innovation to Advance Cell Therapy Manufacturing

The cell therapy processing landscape is poised for continued evolution, driven by technological breakthroughs, regulatory shifts, and global market dynamics. As the industry advances, the convergence of automation, closed-loop systems, and data-centric process control will define the next generation of manufacturing excellence. Stakeholders who embrace collaborative innovation models, invest in local manufacturing capabilities, and adopt scalable, modular architectures will lead the transformation from bespoke interventions to broadly accessible therapies. By aligning strategic priorities with regional opportunities and emerging regulatory frameworks, organizations can unlock the full potential of cell therapy, delivering safe, effective, and cost-efficient treatments to patients worldwide.

Market Segmentation & Coverage

This research report categorizes the Automated & Closed Cell Therapy Processing Systems Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Automated Processing Systems
  • Closed Cell Processing Systems
    • Post-Cryopreservation Systems
    • Pre-Cryopreservation Systems
    • Scalable Systems
  • Open Processing Systems
  • Biopharmaceutical Manufacturing
    • Monoclonal Antibodies
    • Recombinant Proteins
    • Vaccines
      • Prophylactic Vaccines
      • Therapeutic Vaccines
  • Clinical Operations
    • Hematology
    • Oncology
      • Hematologic Malignancies
      • Solid Tumors
    • Patient-Specific Therapy
  • Research Institutes
    • Cell Therapy Research
    • Gene Editing
    • Stem Cell Research
  • Biotechnology Companies
  • Hospitals & Clinics
    • Oncology Clinics
    • Specialized Treatment Centers
  • Pharmaceutical Companies
  • Research & Academic Institutes
  • Cell Cryopreservation
    • Controlled Rate Freezing
    • Vitrification
  • Cell Expansion
  • Cell Harvesting
  • Cell Separation
  • Enzymes
    • Nucleases
    • Proteases
  • Mediums & Supplements
  • Serum-Free Culture Reagents
  • Hardware
    • Bioreactors
    • Centrifuges
  • Services
    • Regulatory Compliance Assistance
    • Validation Services
  • Software
    • Data Analysis
    • Process Monitoring
  • NK Cells
  • Stem Cells
    • Adult Stem Cells
    • Embryonic Stem Cells
  • T-Cells
    • CAR-T Cells
    • Engineered T-Cells
  • Clinical Scale
  • Industrial Scale
  • Research Scale

This research report categorizes the Automated & Closed Cell Therapy Processing Systems Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Automated & Closed Cell Therapy Processing Systems Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Bio-Techne Corporation
  • BioLife Solutions Inc.
  • BioSpherix, Ltd.
  • Cellares Inc.
  • Corning Incorporated
  • Cytiva
  • Danaher Corporation
  • Fresenius SE & Co. KGaA
  • General Electric Company
  • Lonza Group AG
  • Merck KGaA
  • Miltenyi Biotec B.V. & Co. KG
  • Novartis AG
  • Pluristem Therapeutics Inc.
  • Regeneus Ltd.
  • Sartorius AG
  • STEMCELL Technologies Canada Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific, Inc.
  • Thermogenesis Holdings, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Automated & Closed Cell Therapy Processing Systems Market, by Product Type
8.1. Introduction
8.2. Automated Processing Systems
8.3. Closed Cell Processing Systems
8.3.1. Post-Cryopreservation Systems
8.3.2. Pre-Cryopreservation Systems
8.3.3. Scalable Systems
8.4. Open Processing Systems
9. Automated & Closed Cell Therapy Processing Systems Market, by Application
9.1. Introduction
9.2. Biopharmaceutical Manufacturing
9.2.1. Monoclonal Antibodies
9.2.2. Recombinant Proteins
9.2.3. Vaccines
9.2.3.1. Prophylactic Vaccines
9.2.3.2. Therapeutic Vaccines
9.3. Clinical Operations
9.3.1. Hematology
9.3.2. Oncology
9.3.2.1. Hematologic Malignancies
9.3.2.2. Solid Tumors
9.3.3. Patient-Specific Therapy
9.4. Research Institutes
9.4.1. Cell Therapy Research
9.4.2. Gene Editing
9.4.3. Stem Cell Research
10. Automated & Closed Cell Therapy Processing Systems Market, by End User
10.1. Introduction
10.2. Biotechnology Companies
10.3. Hospitals & Clinics
10.3.1. Oncology Clinics
10.3.2. Specialized Treatment Centers
10.4. Pharmaceutical Companies
10.5. Research & Academic Institutes
11. Automated & Closed Cell Therapy Processing Systems Market, by Workflow Process
11.1. Introduction
11.2. Cell Cryopreservation
11.2.1. Controlled Rate Freezing
11.2.2. Vitrification
11.3. Cell Expansion
11.4. Cell Harvesting
11.5. Cell Separation
12. Automated & Closed Cell Therapy Processing Systems Market, by Consumables & Reagents
12.1. Introduction
12.2. Enzymes
12.2.1. Nucleases
12.2.2. Proteases
12.3. Mediums & Supplements
12.4. Serum-Free Culture Reagents
13. Automated & Closed Cell Therapy Processing Systems Market, by Technological Component
13.1. Introduction
13.2. Hardware
13.2.1. Bioreactors
13.2.2. Centrifuges
13.3. Services
13.3.1. Regulatory Compliance Assistance
13.3.2. Validation Services
13.4. Software
13.4.1. Data Analysis
13.4.2. Process Monitoring
14. Automated & Closed Cell Therapy Processing Systems Market, by Type of Cells
14.1. Introduction
14.2. NK Cells
14.3. Stem Cells
14.3.1. Adult Stem Cells
14.3.2. Embryonic Stem Cells
14.4. T-Cells
14.4.1. CAR-T Cells
14.4.2. Engineered T-Cells
15. Automated & Closed Cell Therapy Processing Systems Market, by Manufacturing Scale
15.1. Introduction
15.2. Clinical Scale
15.3. Industrial Scale
15.4. Research Scale
16. Americas Automated & Closed Cell Therapy Processing Systems Market
16.1. Introduction
16.2. Argentina
16.3. Brazil
16.4. Canada
16.5. Mexico
16.6. United States
17. Asia-Pacific Automated & Closed Cell Therapy Processing Systems Market
17.1. Introduction
17.2. Australia
17.3. China
17.4. India
17.5. Indonesia
17.6. Japan
17.7. Malaysia
17.8. Philippines
17.9. Singapore
17.10. South Korea
17.11. Taiwan
17.12. Thailand
17.13. Vietnam
18. Europe, Middle East & Africa Automated & Closed Cell Therapy Processing Systems Market
18.1. Introduction
18.2. Denmark
18.3. Egypt
18.4. Finland
18.5. France
18.6. Germany
18.7. Israel
18.8. Italy
18.9. Netherlands
18.10. Nigeria
18.11. Norway
18.12. Poland
18.13. Qatar
18.14. Russia
18.15. Saudi Arabia
18.16. South Africa
18.17. Spain
18.18. Sweden
18.19. Switzerland
18.20. Turkey
18.21. United Arab Emirates
18.22. United Kingdom
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Bio-Techne Corporation
19.3.2. BioLife Solutions Inc.
19.3.3. BioSpherix, Ltd.
19.3.4. Cellares Inc.
19.3.5. Corning Incorporated
19.3.6. Cytiva
19.3.7. Danaher Corporation
19.3.8. Fresenius SE & Co. KGaA
19.3.9. General Electric Company
19.3.10. Lonza Group AG
19.3.11. Merck KGaA
19.3.12. Miltenyi Biotec B.V. & Co. KG
19.3.13. Novartis AG
19.3.14. Pluristem Therapeutics Inc.
19.3.15. Regeneus Ltd.
19.3.16. Sartorius AG
19.3.17. STEMCELL Technologies Canada Inc.
19.3.18. Terumo Corporation
19.3.19. Thermo Fisher Scientific, Inc.
19.3.20. Thermogenesis Holdings, Inc.
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET MULTI-CURRENCY
FIGURE 2. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET MULTI-LANGUAGE
FIGURE 3. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW PROCESS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW PROCESS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGICAL COMPONENT, 2024 VS 2030 (%)
FIGURE 18. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGICAL COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE OF CELLS, 2024 VS 2030 (%)
FIGURE 20. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE OF CELLS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MANUFACTURING SCALE, 2024 VS 2030 (%)
FIGURE 22. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MANUFACTURING SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOMATED PROCESSING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLOSED CELL PROCESSING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY POST-CRYOPRESERVATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRE-CRYOPRESERVATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SCALABLE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLOSED CELL PROCESSING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY OPEN PROCESSING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PROPHYLACTIC VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY THERAPEUTIC VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLINICAL OPERATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PATIENT-SPECIFIC THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLINICAL OPERATIONS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL THERAPY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SPECIALIZED TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW PROCESS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CONTROLLED RATE FREEZING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY VITRIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL EXPANSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL HARVESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SEPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY NUCLEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PROTEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MEDIUMS & SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SERUM-FREE CULTURE REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGICAL COMPONENT, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY REGULATORY COMPLIANCE ASSISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY VALIDATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PROCESS MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE OF CELLS, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY NK CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ADULT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY T-CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CAR-T CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ENGINEERED T-CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY T-CELLS, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLINICAL SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY INDUSTRIAL SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY RESEARCH SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLOSED CELL PROCESSING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLINICAL OPERATIONS, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW PROCESS, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGICAL COMPONENT, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE OF CELLS, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY T-CELLS, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLOSED CELL PROCESSING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLINICAL OPERATIONS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW PROCESS, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGICAL COMPONENT, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE OF CELLS, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY T-CELLS, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLOSED CELL PROCESSING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLINICAL OPERATIONS, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW PROCESS, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGICAL COMPONENT, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE OF CELLS, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY T-CELLS, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 153. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLOSED CELL PROCESSING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 155. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 157. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 158. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLINICAL OPERATIONS, 2018-2030 (USD MILLION)
TABLE 159. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 160. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 161. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 163. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW PROCESS, 2018-2030 (USD MILLION)
TABLE 164. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 165. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 166. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 167. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGICAL COMPONENT, 2018-2030 (USD MILLION)
TABLE 168. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 169. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 170. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 171. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE OF CELLS, 2018-2030 (USD MILLION)
TABLE 172. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 173. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY T-CELLS, 2018-2030 (USD MILLION)
TABLE 174. CANADA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 175. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLOSED CELL PROCESSING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 177. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 179. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 180. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLINICAL OPERATIONS, 2018-2030 (USD MILLION)
TABLE 181. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 182. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 183. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 185. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW PROCESS, 2018-2030 (USD MILLION)
TABLE 186. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 187. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 188. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 189. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGICAL COMPONENT, 2018-2030 (USD MILLION)
TABLE 190. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 191. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 192. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 193. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE OF CELLS, 2018-2030 (USD MILLION)
TABLE 194. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 195. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY T-CELLS, 2018-2030 (USD MILLION)
TABLE 196. MEXICO AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 197. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLOSED CELL PROCESSING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLINICAL OPERATIONS, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW PROCESS, 2018-2030 (USD MILLION)
TABLE 208. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 209. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 210. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 211. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGICAL COMPONENT, 2018-2030 (USD MILLION)
TABLE 212. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 213. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 214. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 215. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE OF CELLS, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY T-CELLS, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 220. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLOSED CELL PROCESSING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 222. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLINICAL OPERATIONS, 2018-2030 (USD MILLION)
TABLE 226. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY WORKFLOW PROCESS, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL CRYOPRESERVATION, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGICAL COMPONENT, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TYPE OF CELLS, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STEM CELLS, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY T-CELLS, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MANUFACTURING SCALE, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 243. AUSTRALIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. AUSTRALIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLOSED CELL PROCESSING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 245. AUSTRALIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. AUSTRALIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
TABLE 247. AUSTRALIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 248. AUSTRALIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLINICAL OPERATIONS, 2018-2030 (USD MILLION)
TABLE 249. AUSTRALIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 250. AUSTRALIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 251. AUSTRALIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. AUSTRALIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 253. AUSTRALIA AUTOMATED & CLOSED CELL THERAPY PROCESSING SY

Companies Mentioned

  • Bio-Techne Corporation
  • BioLife Solutions Inc.
  • BioSpherix, Ltd.
  • Cellares Inc.
  • Corning Incorporated
  • Cytiva
  • Danaher Corporation
  • Fresenius SE & Co. KGaA
  • General Electric Company
  • Lonza Group AG
  • Merck KGaA
  • Miltenyi Biotec B.V. & Co. KG
  • Novartis AG
  • Pluristem Therapeutics Inc.
  • Regeneus Ltd.
  • Sartorius AG
  • STEMCELL Technologies Canada Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific, Inc.
  • Thermogenesis Holdings, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Automated Cell Processing Systems for Cell Therapy Market - Global Forecast to 2030 - Product Image

Automated Cell Processing Systems for Cell Therapy Market - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
U.S. Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation, Expansion), By Type (Stem Cell Therapy, Non-stem Cell Therapy), By Scale, And Segment Forecasts, 2025 - 2030 - Product Image

U.S. Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation, Expansion), By Type (Stem Cell Therapy, Non-stem Cell Therapy), By Scale, And Segment Forecasts, 2025 - 2030

  • Report
  • 75 Pages
  • United States
From
North America Commercial Wall Water Resistive Barrier Market Size, Share & Trends Analysis Report by Product (Mechanically Attached Sheet, Self-Adhered Sheet), End-use (Commercial, Institutional, Industrial), Country, and Segment Forecasts, 2024-2030 - Product Image

North America Commercial Wall Water Resistive Barrier Market Size, Share & Trends Analysis Report by Product (Mechanically Attached Sheet, Self-Adhered Sheet), End-use (Commercial, Institutional, Industrial), Country, and Segment Forecasts, 2024-2030

  • Report
  • 67 Pages
  • North America
From
Automated and Closed Cell Therapy Processing Systems - Global Strategic Business Report - Product Image

Automated and Closed Cell Therapy Processing Systems - Global Strategic Business Report

  • Report
  • 138 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.